SMAD6
protein-codingSMAD family member 6, the group of SMAD family
Gene summary
The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila 'mothers against decapentaplegic' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]
- MADH7
- MADH6
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~80.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0044315
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100183
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0700324
Submitter: ClinGen
SMAD6 was first reported in relation to autosomal dominant SMAD6-related disease in 2016 (Timberlake et al., PMID: 27606499). SMAD6-related disease is the presentation of craniosynostosis with congenital heart defects and/or radioulnar synostosis. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism or inheritance pattern. Variants in SMAD6 causing aortic valve disease, craniosynostosis, and radioulnar synostosis were located throughout the gene. Reports have also shown various syndromic presentations of SMAD6 variants. Therefore, the following disease entities have been lumped into one disease entity, Aortic Valve Disease 2 (OMIM:614823), Craniosynostosis 7 (OMIM:617439), and Radioulnar Synostosis (OMIM:179300). 28 variants (missense, nonsense, and frameshift) that have been reported in 28 probands in 3 publications (PMIDs: 34953066, 32499606, 27606499) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by animal models and expression studies (PMIDs: 21681813, 10655064). SMAD6 was found to be expressed in developing cardiac tissue and bones, and mice deficient in SMAD6 were found to exhibit phenotypes similar to aortic valve disorder and craniosynostosis. In summary, SMAD6 is definitively associated with autosomal dominant SMAD6-related disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 06/15/2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0000119
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007194
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0044315
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013902
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0017985
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0044315
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0044315
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013902
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100183
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0013902
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: Individuals may manifest with sequelae of cardiovascular anomalies including bicuspid, aortic valve, aortic stenosis, and aortic coarctation, and awareness may allow early detection and medical/surgical management, which may ameliorate morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SMAD6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005585.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 326 | 1 | 327 | |||
| missense | 4 | 11 | 687 | 35 | 1 | 738 |
| nonsense | 13 | 31 | 36 | 80 | ||
| start loss | 1 | 5 | 6 | |||
| frameshift | 19 | 39 | 88 | 146 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 11 | 13 | ||
| Total | 37 | 83 | 827 | 361 | 2 | 1310 |
Highest pathogenic variant AF is 0.000016379667
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005576.3 | 4 | MANE Select | |
| Ensembl | ENSP00000288840.5 | 4 | MANE Select | |
| Ensembl | ENSP00000452955.1 | 4 | Standard | |
| Ensembl | ENSP00000452694.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- TGF-Ncore
- EGF-Ncore
- Bone Morphogenic Protein (BMP) Signalling and Regulation
- Regulation of toll-like receptor signaling pathway
Biological Process
- ureteric bud development
- outflow tract septum morphogenesis
- aortic valve morphogenesis
- mitral valve morphogenesis
- pulmonary valve morphogenesis
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- chromatin binding
- protein binding
- transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity
Cellular Component
- nucleus
- transcription factor complex
- cytoplasm
- Golgi apparatus
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000288840
- Coding exons
- 4
- Length
- 79773
- Individuals with no LoFs
- 125697
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 51
- Defined
- 125748
- p
- 0.000203
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.592 | 249 | 224 | 1.11 | 0.0000152 | 3019 |
| Missense (PolyPhen) | 97 | 101.18 | 0.95873 | 1142 | ||
| Synonymous | 0.372 | 108 | 113 | 0.955 | 0.00000905 | 1080 |
| Loss of Function | -3.07 | 23 | 11.7 | 1.97 | 5.85e-7 | 155 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00029 | 0.00025 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00024 | 0.00018 | rare |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.00033 | 0.00029 | rare |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a mediator of TGF-beta and BMP antiflammatory activity. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of proinflammatory genes. May block the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding. Binds to regulatory elements in target promoter regions. {ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:16951688, ECO:0000269|PubMed:9436979}.;
- Disease
- DISEASE: Aortic valve disease 2 (AOVD2) [MIM:614823]: A common defect in the aortic valve in which two rather than three leaflets are present. It is often associated with aortic valve calcification, stenosis and insufficiency. In extreme cases, the blood flow may be so restricted that the left ventricle fails to grow, resulting in hypoplastic left heart syndrome. {ECO:0000269|PubMed:22275001}. Note=The disease is caused by mutations affecting the gene represented in this entry. SMAD6 variants may contribute to increased risk of congenital cardiovascular malformations (CVM). CVM is a major cause of mortality and morbidity in childhood. In most sporadic cases that cannot be attributed to particular malformation syndromes or teratogenic exposures, there remains a substantial excess familial risk, indicating a significant genetic contribution to disease susceptibility (PubMed:22275001). {ECO:0000269|PubMed:22275001}.; DISEASE: Craniosynostosis 7 (CRS7) [MIM:617439]: A form of craniosynostosis, a primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:27606499}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Rare heterozygous SMAD6 variants are strongly associated with non-syndromic midline craniosynostosis and confer a very high risk for disease development, in the presence of a common risk allele (rs1884302) near the BMP2 locus. {ECO:0000269|PubMed:27606499}.;
Recessive Scores
- pRec
- 0.260
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.998
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |